Skip to content

Alessandro Ceschi

2 papers in the library · 1 citation · publishing 2014-2025

Papers

Differences in the clinical presentation of acute 3,4-methylenedioxymetamfetamine intoxication by co-intoxication and patient sex to European emergency departments.

Clinical toxicology (Philadelphia, Pa.) March 1, 2025 Joep J. J. Ouwerkerk, David M. Wood, Alison M. Dines et al. 1 citation

When 3,4-methylenedioxymetamfetamine (MDMA) is taken with alcohol, emergency department visits show higher odds of agitation, drowsiness, and vomiting compared to MDMA alone. Co-intoxication with other substances increases odds of bradycardia, psychosis, and coma. Mortality rates remain low across all groups. Female patients report less chest pain but more vomiting, headache, and hypotension than males. These variations suggest that physicians should consider both the type of co-intoxication and patient sex to optimize treatment.

Acute toxicity associated with the recreational use of the novel dissociative psychoactive substance methoxphenidine.

Clinical toxicology (Philadelphia, Pa.) December 1, 2014 Katharina E Hofer, Colette Degrandi, Daniel M Müller et al.

Methoxphenidine, a novel dissociative designer drug of the diarylethylamine class with structural features similar to phencyclidine (PCP), produced PCP-like adverse effects in a 53-year-old man found on the street in a somnolent and confusional state. Observed signs included tachycardia (112 bpm), hypertension (220/125 mmHg), echolalia, confusion, agitation, opisthotonus, nystagmus, and amnesia. Temperature and oxygen saturation were normal. Laboratory findings showed elevated creatine kinase (max 865 U/L), alanine aminotransferase (72 U/L), and gamma-glutamyl transpeptidase (123 U/L). Methoxphenidine was confirmed in plasma and urine via liquid chromatography tandem mass spectrometry. The patient recovered with symptomatic treatment.